Cytosorbents Corp - CTSO - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Cytosorbents Corp - SIC # 3845

Ticker	Exchange	SIC #	Website	Latest Ticker
CTSO	Over the counter	3845	http://www.cytosorbents.com/	0.126 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Cytosorbents Corp 6.17.13 CytoSorbents Announces FDA Approved US Air Force Funded Human Trauma Pilot Study for Rhabdomyolysis - Jun 19th, 2013 6:43 pm CytoSorbents Announces FDA Approved US Air Force Funded Human Trauma Pilot Study for Rhabdomyolysis - Jun 17th, 2013 6:00 am CytoSorbents Enters Into Exclusive Distribution Agreement for CytoSorb(R) With Hitit Medical Systems in Turkey - Jun 13th, 2013 7:00 am CTSO: Tiny Med-Tech With Huge Potential - Jun 10th, 2013 6:30 am CYTOSORBENTS CORP Financials - Jun 5th, 2013 11:04 am CytoSorbents Featured in MedCity News - May 29th, 2013 7:00 am Alliance Advisors Announces Sponsorship of Marcum MicroCap Conference - May 22nd, 2013 6:00 am Awareness-Building Efforts Bearing Fruit - May 17th, 2013 9:30 am CytoSorbents Reports 2013 First Quarter Financial Results - May 16th, 2013 5:00 am CYTOSORBENTS CORP Files SEC form 10-Q, Quarterly Report - May 15th, 2013 8:15 am CYTOSORBENTS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits - May 13th, 2013 9:04 pm Kathleen P. Bloch Appointed as Chief Financial Officer of CytoSorbents - May 13th, 2013 6:00 am CytoSorbents Enters Into Exclusive Distribution Agreement for CytoSorb(R) With L.IN.C. Medical Systems in the United Kingdom and Ireland - May 6th, 2013 6:01 am CytoSorbents CEO Provides Exclusive Interview With medGadget - May 1st, 2013 7:30 am CytoSorbents Appoints Christopher Cramer as Vice President of Business Development - Apr 15th, 2013 6:00 am CytoSorbents Awarded Additional Phase I Option on US Army SBIR Trauma Contract - Apr 11th, 2013 7:00 am CytoSorbents Announces Trauma Advisory Board - Apr 8th, 2013 6:00 am Q4 Results / Interest In CytoSorb Accelerating - Apr 4th, 2013 4:30 am CytoSorbents Provides Corporate Update and Reports 2012 Year End Financial Results - Apr 3rd, 2013 7:00 am CYTOSORBENTS CORP Files SEC form 10-K, Annual Report - Apr 2nd, 2013 10:59 pm View All Current Headlines >>